Fig. 7.
HILIC-FT-MS oligosaccharides mapping of enoxaparin. ANOVA was used for comparison of high and low affinity enoxaparin to original enoxaparin, * for 0.01<p<0.05, ** for p<0.01. A. Enoxaparin whose non-reducing end was saturated, B. Enoxaparin whose non-reducing end was unsaturated, C. Enoxaparin whose reducing end was 1,6-anhydro.